Use of an antibody or its functional fragments capable of binding to CD151 protein and inhibiting the tumor growth for the preparation of medicament to treat cancer, where the cancer is colon, lung, prostate or pancreatic cancer

摘要

Use of an antibody, or one of its functional fragments capable of binding to cluster of differentiation (CD)-151 protein and inhibiting the tumor growth for the preparation of a medicament for the treatment of cancer, is claimed. An independent claim is included for a composition for treating cancer, comprising the anti-CD151 antibody as active ingredient, which binds to the protein CD151 and/or to inhibit its metastasis promoting activity. ACTIVITY : Cytostatic. MECHANISM OF ACTION : CD151 protein binder.